The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

Malcolm Ethridge, Capital Area Planning Group managing partner, joined CNBC to talk about where the market could go and his ...

NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its ...

According to The Insight Partners study on the Radiation Oncology Market is observing significant growth owing to the ...

October 7, 2024 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including biotech stocks reports on trading and news ...

The global high potency API (HPAPI) contract manufacturing market achieved a market value of USD 8 billion in 2022 and is ...

Diakonos’ dendritic cell vaccine represents a unique approach for engaging an immune response against a patient’s cancer.

Learn how the right NGS technology can enhance clinical research while supporting downstream efforts toward global commercialization.

One of the main advantages of choosing a fellowship-trained breast surgeon is the mastery of advanced techniques that ...

The Swiss market recently demonstrated resilience by rebounding from a weak start, buoyed by the European Central Bank's interest rate cut to 3.25%, which helped lift the SMI index by 0.91% to close ...

AKT1 E17K mutation is a clinically validated oncogene that impacts greater than 40,000 cancer patients per year in the United States, with the highest prevalence in breast, endometrial, and prostate ...

Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in ...